Effect of Combination Therapy with Atorvastatin and Ursodeoxycholic Acid on the Course of Ischemic Heart Disease with Co-Existent Non-Alcoholic Fatty Liver Disease and Obesity
Non-alcoholic fatty liver disease is considered as an independent predictor of cardiovascular diseases which plays an important role in the development of ischemic heart disease. The drug most frequently used for treating this comorbidity is atorvastatin which favours better survival outcomes and is...
Saved in:
Main Author: | |
---|---|
Format: | EJournal Article |
Published: |
Ivano-Frankivsk National Medical University,
2016-12-12.
|
Subjects: | |
Online Access: | Get Fulltext Get Fulltext |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!